Table 1.
Patient data | Sinus rhythm (n = 34) | Atrial fibrillation (n = 10) | Non-failing ventricle (n = 10)a |
---|---|---|---|
Male sex (%) | 73.5 | 50.0 | N/A |
Age (Mean ± SEM, y) | 64.56 ± 1.55 | 75.2 ± 2.55 | N/A |
EF (Mean ± SEM, %) | 56.89 ± 1.95 | 51.25 ± 3.03 | N/A |
Ischemic heart disease (%) | 100.0 | 100.0 | N/A |
Diabetes (%) | 41.4 | 20.0 | N/A |
ACE inhibitors (%) | 83.3 | 80.0 | N/A |
β-Blockers (%) | 81.8 | 100.0 | N/A |
Digoxin (%) | 0.0 | 0.0 | N/A |
Catecholamines (%) | 0.0 | 0.0 | N/A |
Amiodaron (%) | 0.0 | 30.0 | N/A |
PDE inhibitors (%) | 0.0 | 0.0 | N/A |
Statin (%) | 83.9 | 90.0 | N/A |
Values are mean ± SEM or n (%). Clinical data could not be completely obtained from every patient
EF ejection fraction, ACE angiotensin-converting enzyme, PDE phosphodiesterase
aBlinded due to ethical reasons